A surveillance network for meningococcal disease in Europe

Caroline L Trotter1, Manosree Chandra, Rosa Cano

  • 1Immunization Department, Health Protection Agency Centre for Infections, London, UK.

FEMS Microbiology Reviews
|December 16, 2006
PubMed

Insights

Routine vaccination against meningococcal serogroup C infection significantly reduced invasive disease incidence in Europe. Surveillance data also confirmed W135 and B2a/B2b strains did not emerge as major public health threats.

Area of Science:

  • Epidemiology
  • Microbiology
  • Public Health

Background:

  • The European Union Invasive Bacterial Infections Surveillance Network (EU-IBIS) collected approximately 50,000 reports of meningococcal disease between 1999 and 2004.
  • Routine vaccination against serogroup C meningococcal infection has been implemented in several European countries.

Purpose of the Study:

  • To analyze trends in invasive meningococcal disease incidence across Europe.
  • To monitor the emergence of specific meningococcal strains (W135, B2a/B2b).
  • To enhance data resources and collaborative projects through the EU-MenNet initiative.

Main Methods:

  • Analysis of surveillance data from the EU-IBIS network.
  • Rapid reporting systems for emerging meningococcal strains.
  • Collaborative projects including website improvement, case ascertainment review, cost-effectiveness studies, vaccine efficacy comparisons, and mathematical modeling.
  • Linking epidemiological data with multi-locus sequence typing data.

Main Results:

  • A significant decline in invasive meningococcal disease incidence was observed in countries with routine serogroup C conjugate (MCC) vaccination.
  • Emerging W135 and B2a/B2b strains were monitored, with no indication of them becoming major public health issues.
  • Specific clonal complexes were associated with particular serogroups, and case fatality varied with clonal complex, suggesting genotype may indicate hypervirulence.

Conclusions:

  • Routine MCC vaccination is effective in reducing invasive meningococcal disease.
  • Robust surveillance systems are crucial for monitoring bacterial infections and emerging strains.
  • Collaboration among epidemiologists, microbiologists, and public health professionals is vital for effective disease control.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...